GOOD SAMARITAN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.8M
- Transactions
- 1,376
- Companies
- 40
- Average per transaction
- $4,934
Who reported the payments
| Novartis | $1,924,946 |
| Takeda Pharmaceuticals U.S.A., Inc. | $932,440 |
| Merck | $470,187 |
| Amgen | $448,778 |
| Genentech, Inc. | $421,910 |
| Ares Trading SA | $291,075 |
| Tandem Diabetes Care, Inc. | $171,000 |
| AbbVie | $168,796 |
| Eli Lilly | $145,691 |
| Intuitive Surgical | $133,482 |
| Pfizer | $116,170 |
| Medtronic | $115,482 |
| E.r. Squibb & Sons, L.L.C. | $111,933 |
| Stryker | $91,050 |
| Angiodynamics, Inc. | $78,083 |
| Janssen Research & Development, LLC | $73,790 |
| Barco, Inc. | $73,350 |
| Edwards Lifesciences | $71,851 |
| Artivion, Inc. | $66,719 |
| Boston Scientific | $60,012 |
| Sanofi | $57,342 |
| W. L. Gore & Associates, Inc. | $52,558 |
| F. Hoffmann-la Roche AG | $46,241 |
| Johnson & Johnson | $46,156 |
| KCI USA, Inc. | $44,560 |
| Abbott | $36,910 |
| Gynesonics, Inc. | $36,191 |
| Standard Bariatrics, Inc. | $36,025 |
| Aadi Bioscience, Inc. | $35,531 |
| Novocure GmbH | $32,946 |
| Antares Pharma, Inc. | $31,372 |
| AstraZeneca | $21,159 |
| Medartis Inc. | $21,138 |
| Penumbra, Inc. | $20,181 |
| Actelion Pharmaceuticals, Ltd | $16,350 |
| Sanofi US Services Inc. | $15,952 |
| Bristol Myers Squibb | $15,500 |
| Allen Medical Systems | $15,008 |
| Orthosensor Inc. | $14,188 |
| EKOS Corporation | $14,014 |